|
Volumn 28, Issue 4, 2015, Pages 401-402
|
Shifting the Evolving CAR T Cell Platform into Higher Gear
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CD137 LIGAND;
CD28 ANTIGEN;
CD3 ANTIGEN;
CHIMERIC ANTIGEN RECEPTOR;
CD137 ANTIGEN;
LYMPHOCYTE ANTIGEN RECEPTOR;
CANCER PATIENT;
CD3+ T LYMPHOCYTE;
CD8+ T LYMPHOCYTE;
CELL EXPANSION;
CELL SURVIVAL;
CYTOTOXICITY;
HUMAN;
IMMUNOCOMPETENT CELL;
IN VITRO STUDY;
IN VIVO STUDY;
LYMPHOCYTE PROLIFERATION;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
SHORT SURVEY;
SIGNAL TRANSDUCTION;
T LYMPHOCYTE;
TUMOR MICROENVIRONMENT;
HEMATOLOGIC DISEASE;
IMMUNOLOGY;
ANTIGENS, CD137;
ANTIGENS, CD28;
HEMATOLOGIC NEOPLASMS;
HUMANS;
RECEPTORS, ANTIGEN;
T-LYMPHOCYTES;
|
EID: 84944056465
PISSN: 15356108
EISSN: 18783686
Source Type: Journal
DOI: 10.1016/j.ccell.2015.09.014 Document Type: Short Survey |
Times cited : (10)
|
References (8)
|